2026 Korean Society for Biochemistry and Molecular Biology (KSBMB) International Conference

The 2026 Korean Society for Biochemistry and Molecular Biology (KSBMB) International Conference will be held from May 28–30, 2026, at BEXCO in Busan, South Korea.

Illumina will participate in KSBMB 2026 to engage with the broader life science research community and demonstrate how integrated multiomics and AI-enabled analytics are transforming biological discovery.

Aligned with the conference theme focusing on AI and big data in life science, Illumina will showcase its expanding multiomics portfolio spanning genomics, transcriptomics, proteomics, bioinformatics, and population-scale research.

At the Illumina booth, we will highlight our end-to-end ecosystem by demonstrating scalable sequencing platforms and advanced informatics solutions that enable system-level and data-driven research.

In addition, Illumina will present how DRAGEN and Illumina software solutions deliver fast, accurate, and scalable analysis across multiple omics applications, supporting researchers from data generation to interpretation.

Through both booth engagement and the satellite session, Illumina aims to provide practical insights and reinforce its leadership in enabling integrated, AI-driven multiomics research.

Session Details

The Illumina-sponsored satellite session will highlight the latest advancements in multiomics, bioinformatics, and population genomics, aligned with KSBMB’s focus on AI and big data-driven life science research.

Program Agenda

• Keynote (11:00–11:10)
  Professor Hanjin (Inje University College of Medicine)
  • Opening keynote presentation
• Multiomics (11:10–11:40)
  Joel Fellis, Ph.D. | Illumina Inc.
  • Integrated biological research approaches leveraging multiomics technologies
• Bioinformatics (11:40–12:10)
  JP Chaib | Illumina Inc.
  • Latest trends in bioinformatics for large-scale genomics and multiomics data analysis
• Population Genomics (12:10–12:40)
  Helen Speirs, Ph.D. | Illumina Australia
  • Applications of pangenome analysis for disease research and population-level genome interpretation

This session will demonstrate how Illumina’s integrated solutions enable researchers to connect multiomics technologies with scalable informatics, accelerating discovery and enabling deeper biological insights across research domains.